Lpath's (LPTN.OB) Lpathomab treatment performed well in tests on mice with partially severed...


Lpath's (LPTN.OB) Lpathomab treatment performed well in tests on mice with partially severed spinal cords. Lpath says Lpathomab "reverses much of the damage caused by trauma to the nervous system," bringing scientists closer to finding a treatment for spinal cord injury. The results of the study have been published in the American Journal of Pathology. (PR)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs